XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 43,635 $ 287,000,021 $ 2,329,195 $ (253,997,878) $ 35,374,973
Balance (in shares) at Dec. 31, 2022 43,635,715        
Stock-based compensation - employees, consultants and directors   1,400,516     1,400,516
Issuance of common stock offerings, net of fees $ 428 1,474,296     1,474,724
Issuance of common stock offerings, net of fees (in shares) 428,270        
Legal/audit fees related to ATM offering   (56,702)     (56,702)
Proceeds from exercise of stock options for cash $ 75 197,304     197,379
Proceeds from exercise of stock options for cash (in shares) 74,393        
Issuance of restricted stock units $ 55 183,600     183,655
Issuance of restricted stock units (in shares) 55,318        
Other comprehensive income (loss): foreign translation adjustment     (1,000,882)   (1,000,882)
Net loss       (13,478,967) (13,478,967)
Balance at Jun. 30, 2023 $ 44,193 290,199,035 1,328,313 (267,476,845) 24,094,696
Balance (in shares) at Jun. 30, 2023 44,193,696        
Balance at Dec. 31, 2022 $ 43,635 287,000,021 2,329,195 (253,997,878) 35,374,973
Balance (in shares) at Dec. 31, 2022 43,635,715        
Balance at Dec. 31, 2023 $ 54,240 305,196,874 529,321 (282,505,272) 23,275,163
Balance (in shares) at Dec. 31, 2023 54,240,265        
Balance at Mar. 31, 2023 $ 43,851 288,514,368 1,720,987 (261,323,761) 28,955,445
Balance (in shares) at Mar. 31, 2023 43,851,380        
Stock-based compensation - employees, consultants and directors   570,235     570,235
Issuance of common stock offerings, net of fees $ 231 776,060     776,291
Issuance of common stock offerings, net of fees (in shares) 230,605        
Proceeds from exercise of stock options for cash $ 56 154,772     154,828
Proceeds from exercise of stock options for cash (in shares) 56,393        
Issuance of restricted stock units $ 55 183,600     183,655
Issuance of restricted stock units (in shares) 55,318        
Other comprehensive income (loss): foreign translation adjustment     (392,674)   (392,674)
Net loss       (6,153,084) (6,153,084)
Balance at Jun. 30, 2023 $ 44,193 290,199,035 1,328,313 (267,476,845) 24,094,696
Balance (in shares) at Jun. 30, 2023 44,193,696        
Balance at Dec. 31, 2023 $ 54,240 305,196,874 529,321 (282,505,272) 23,275,163
Balance (in shares) at Dec. 31, 2023 54,240,265        
Stock-based compensation - employees, consultants and directors   1,562,788     1,562,788
Warrants issued in connection with long-term debt   690,709     690,709
Issuance of common stock offerings, net of fees $ 54 53,186     53,240
Issuance of common stock offerings, net of fees (in shares) 53,290        
Issuance of restricted stock units $ 12 11,201     11,213
Issuance of restricted stock units (in shares) 12,860        
Other comprehensive income (loss): foreign translation adjustment     1,644,497   1,644,497
Net loss       (10,501,007) (10,501,007)
Balance at Jun. 30, 2024 $ 54,306 307,514,758 2,173,818 (293,006,279) 16,736,603
Balance (in shares) at Jun. 30, 2024 54,306,415        
Balance at Mar. 31, 2024 $ 54,294 305,984,268 1,752,496 (288,863,133) 18,927,925
Balance (in shares) at Mar. 31, 2024 54,293,555        
Stock-based compensation - employees, consultants and directors   828,580     828,580
Warrants issued in connection with long-term debt   690,709     690,709
Issuance of restricted stock units $ 12 11,201     11,213
Issuance of restricted stock units (in shares) 12,860        
Other comprehensive income (loss): foreign translation adjustment     421,322   421,322
Net loss       (4,143,146) (4,143,146)
Balance at Jun. 30, 2024 $ 54,306 $ 307,514,758 $ 2,173,818 $ (293,006,279) $ 16,736,603
Balance (in shares) at Jun. 30, 2024 54,306,415